European Archives - Page 409 of 1050 - European Medical Journal

Interview: Vivek Bhalla

The primary reason is that it’s the most impactful disease that affects nephrology. When I was in training, there was only one medicine…

New Nephrology Feature Image

Focal Segmental Glomerulosclerosis: Histopathology Discussion

In focal segmental glomerulosclerosis (FSGS), some (not all) glomeruli are affected with sclerosis (focal), and each diseased glomerulus…

New Nephrology Feature Image

Management of Anaemia in Patients Undergoing Haemodialysis and With Minor Thalassaemia

Thalassemia is a group of haemoglobinopathies characterised by the decrease or lack of β or α globin chain production haemoglobin (Hb)…

New Nephrology Feature Image

Editor’s Pick: The Renal Effects of SGLT2 Inhibitors

Sodium–glucose co-transporters (SGLT) play an important role in glucose transport across epithelial cells. SGLT1….

New Nephrology Feature Image

COVID-19-Associated Nephropathy: An Emerging Clinical Entity

In this article, the authors present the pathophysiology behind SARS-CoV-2-related kidney involvement and the development of COVID-19-associated nephropathy.

New Nephrology Feature Image

Low-Dose Dopamine in the Management of Intradialysis Hypotension: A Retrospective Cohort Study in Nigeria

Intradialysis hypotension (IDH) commonly complicates haemodialysis treatment, and could be associated with dysfunction…

New Nephrology Feature Image

Pathophysiology of Diabetic Kidney Disease

Diabetic kidney disease (DKD) has been an immense burden on the healthcare system, and is the leading cause of end stage kidney disease…

New Nephrology Feature Image

SGLT2 Inhibitors for Nephrologists

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are the mainstay of therapy for…

The unconscious mind of non-adherence

Non-adherence to medication can be caused by a range of factors, including unconscious biases. How can pharma rework current models to ensure they are connecting with patients?

Cardiology CP

Editor's Pick: Screening for Heart Disease in the Age of Digital Health Technologies: Who, When, and How?

This article will focus on how the emerging field of digital health technology can aid screening for heart disease and explore its usefulness in disease specific and population specific groups.